| Bronchial asthma is a serious health problem in the worldwide. According to statistics, there are around 150 million people suffer from bronchial asthma. The adult-onset rate of china is 0.7%-1.5%, children is 0.7%-2.03%. The incidence of BA in the world is on the rise. According to the Global Initiative for Asthma (GINA,2004), will be a joint long-acting inhaled corticosteroids as aβ2-agonist of choice for asthma prevention and treatment programs.[1]However, inhaled glucocorticoid administration method inevitably brings oropharyngeal adverse reactions that may affect child development, affect bone deposition and other adverse reactions and steroid-resistant and so on. BA is still the current lack of a long-acting and specific treatment, while the long-term treatment for patients of the larger economic pressures, but also bring a lot of social problems. Therefore, the effective prevention and treatment of this disease has become the clinical and scientific research hot spots. The treatment of Heat-Sensitive Acupoints Moxibustion on this disease is unique and positive effect. The topic of adoption of acupoints moxibustion thermal treatment of the disease were observed before and after treatment symptom score, as well as the changes in pulmonary ventilation function to explore the thermal Moxibustion treatment of bronchial asthma of the clinical effects for the treatment of the disease to provide scientific experimental basis.42 cases of BA patients selected from Wuhan Chinese and Western Medicine Hospital were involved in the clinical observation, and were randomized into 2 groups by the randomized center as the treatment group, the drug control group,21 cases in each group. Patients in the treated group received treatment of Heat-Sensitive Acupoints of moxibustion; Hand-held control ignited moxa-ching, in the dorsal lateral foot sun Bladder two lines within the Point Geshu Feishu and the area between the two horizontal distance from the skin surface of about 3cm high degree of implementation of mild moxibustion. To find out the Heat-Sensitive Acupoints by hanging moxibustion, moxibustion to the points in this sense of mass loss, until skin burning up. The first course of treatment for 6 consecutive days, day 1, after 24 days to ensure 12 treatment; after two courses to ensure treatment of 15 times a month (daily≤1 times).There are 21 cases in Drug control group, using the British company GlaxoSmithKline's Seretide 50μg/250μg (salmeterol 50μg /fluticasone propionate 250μg), each time a suction,2 times a day. Even the number needed to treat 3 months later to observe the two groups before and after treatment and efficacy evaluation of symptom score, pulmonary function changes. 1 Comparison of Symptom score:Before treatment, patients with symptom score differences between the two groups had no significant (P>0.05), does not have statistical significance. After treatment, the treatment group and drug group patients Syndrome points were significantly increased compared with before treatment, there is a very significant difference (P<0.01); the treatment group and drug group, there is a significant difference (P<0.05). Tip:The treatment group, treatment group were to improve the role of clinical symptoms, the treatment group in improving the clinical symptoms is superior to drug therapy group.2 Comparison of clinical efficacy:Clinical Comparison of two groups:treatment group 21 cases, control 15 cases, partial control in 4 cases,2 cases, the total effective rate was 90.5%; drug control group,21 cases, control 12 cases, partial control in 4 cases, ineffective in 5 cases, the total efficiency 76.2%. The treatment group and drug group, P<0.05, efficiency of two groups was statistically significant, indicating the treatment group more effective than drug group.3 Two groups compared pulmonary function:Before treatment, the treatment group and drug group on the pulmonary function there was no significant difference (P>0.05). After treatment, the treatment group compared with the group before treatment, there is a significant difference (P<0.01); Drug group compared with the group before treatment, there is a significant difference (P <0.01); The treatment group than in the drug group in improving lung function in patients with the above is not very significant difference (P>0.05).4 Safety observation:Both patients had no apparent adverse reactions, patients can be tolerated, two patients were completion of the pilot, there is no cases of serious adverse reactions due to interruption of treatment.The moxibustion of Heat-Sensitive Acupoint can significantly increase the clinical symptom score in patients with bronchial asthma and improve clinical symptoms, improve clinical efficacy. The duration of the treatment of chronic.asthma, the best effective way to control chronic asthma, the incidence of remission, a significant reduction in the occurrence of clinical symptoms, significant improvement in patients with pulmonary function, and easy to operate, and even patients can operate on their own at home. Security, no pain, no side effects, deserves further study and outreach.
|
PDF Full Text Request